Biotech Values

[drbio45]

A sure thing is all relative - but I'd give odds of pain label approval based upon the current trial data at greater than 95%. But if you feel there is something fishy, feel free to go short -g-.

I never said you implied that approval was a sure thing, I just asked you what made you or the company so sure it could get approved based on one trial that met the endpoint and one trial that missed.

Can you show me one other time in the last 3 years where the fda approved a drug with a missed phase 3 in a non-life threatening disease.

If you provide me with that I may not be so skeptical, not that my skepticism matters.